Is Delcath Systems, Inc. (DCTH) a Buy, Sell, or Hold?
NASDAQ : DCTH
Delcath Systems, Inc. — Insider Trades
$12.1823 USD
-$0.25 (-1.99%)
- Volume
- 193.22K
- Average Volume
- 475.3K
- Market Capitalization
- $420.55M
- P/E Ratio
- 761.39
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $13.74
- Year Low
- $8.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.24
Insider Activity Summary (Last 12 Months)
Insiders Buying
30
Insiders Selling
1
Amount of Insider Selling
$42000
DCTH Insider Buying/Selling by Quarter
DCTH Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Sylvester John Richard | director | 2026-05-13 | A-Award | 11.61 | 2026-05-14 |
| Martell Bridget A | director | 2026-05-13 | A-Award | 11.61 | 2026-05-14 |
| CZEREPAK ELIZABETH | director | 2026-05-13 | A-Award | 11.61 | 2026-05-14 |
| SALAMON STEVEN A J | director | 2026-05-13 | A-Award | 11.61 | 2026-05-14 |
| Aharon Gil | director | 2026-05-13 | A-Award | 11.61 | 2026-05-14 |
| Pennell Sandra | officer: Chief Financial Officer | 2026-03-06 | P-Purchase | 9.04 | 2026-03-06 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2026-03-02 | P-Purchase | 8.9562 | 2026-03-03 |
| Hoffman David L. | officer: GEN'L COUNSEL, CCO & SECY | 2026-02-17 | A-Award | 9.4 | 2026-02-18 |
| Hoffman David L. | officer: GEN'L COUNSEL, CCO & SECY | 2026-02-17 | A-Award | 0 | 2026-02-18 |
| Muir Kevin | officer: GM INTERVENTIONAL ONCOLOGY | 2026-02-17 | A-Award | 9.4 | 2026-02-18 |
| Muir Kevin | officer: GM INTERVENTIONAL ONCOLOGY | 2026-02-17 | A-Award | 0 | 2026-02-18 |
| Pennell Sandra | officer: Chief Financial Officer | 2026-02-17 | A-Award | 9.4 | 2026-02-18 |
| Pennell Sandra | officer: Chief Financial Officer | 2026-02-17 | A-Award | 0 | 2026-02-18 |
| Vukovic Vojo | officer: CHIEF MEDICAL OFFICER | 2026-02-17 | A-Award | 9.4 | 2026-02-18 |
| Vukovic Vojo | officer: CHIEF MEDICAL OFFICER | 2026-02-17 | A-Award | 0 | 2026-02-18 |
| Rook Martha S. | officer: CHIEF OPERATING OFFICER | 2026-02-17 | A-Award | 9.4 | 2026-02-18 |
| Rook Martha S. | officer: CHIEF OPERATING OFFICER | 2026-02-17 | A-Award | 0 | 2026-02-18 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-17 | A-Award | 9.4 | 2026-02-18 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-17 | A-Award | 0 | 2026-02-18 |
| Sylvester John Richard | director | 2025-11-21 | P-Purchase | 8.89 | 2025-11-25 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2025-11-11 | P-Purchase | 8.526 | 2025-11-13 |
| Vukovic Vojo | officer: CHIEF MEDICAL OFFICER | 2025-06-12 | M-Exempt | 4.78 | 2025-06-13 |
| Vukovic Vojo | officer: CHIEF MEDICAL OFFICER | 2025-06-12 | M-Exempt | 4.78 | 2025-06-13 |
| Sylvester John Richard | director | 2025-05-15 | A-Award | 16.05 | 2025-05-19 |
| SALAMON STEVEN A J | director | 2025-05-15 | A-Award | 16.05 | 2025-05-19 |
| CZEREPAK ELIZABETH | director | 2025-05-15 | A-Award | 16.05 | 2025-05-19 |
| Aharon Gil | director | 2025-05-15 | A-Award | 16.05 | 2025-05-19 |
| Martell Bridget A | director | 2025-05-15 | A-Award | 16.05 | 2025-05-19 |
| Aharon Gil | director | 2025-05-05 | X-InTheMoney | 10 | 2025-05-09 |
| SALAMON STEVEN A J | director | 2025-05-05 | X-InTheMoney | 10 | 2025-05-09 |
| Rosalind Advisors, Inc. | director | 2025-05-05 | X-InTheMoney | 10 | 2025-05-09 |
| Hoffman David L. | officer: GEN'L COUNSEL, CCO & SECY | 2025-02-07 | A-Award | 16.25 | 2025-02-07 |
| Pennell Sandra | officer: Chief Financial Officer | 2025-02-07 | A-Award | 16.25 | 2025-02-07 |
| Muir Kevin | officer: GM INTERVENTIONAL ONCOLOGY | 2025-02-07 | A-Award | 16.25 | 2025-02-07 |
| Rook Martha S. | officer: CHIEF OPERATING OFFICER | 2025-02-07 | A-Award | 16.25 | 2025-02-07 |
| Vukovic Vojo | officer: CHIEF MEDICAL OFFICER | 2025-02-07 | A-Award | 16.25 | 2025-02-07 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2025-02-07 | A-Award | 16.25 | 2025-02-07 |
| SALAMON STEVEN A J | director | 2024-12-24 | C-Conversion | 10 | 2024-12-27 |
| SALAMON STEVEN A J | director | 2024-12-24 | M-Exempt | 0.01 | 2024-12-27 |
| Aharon Gil | director | 2024-12-24 | C-Conversion | 10 | 2024-12-26 |
| Aharon Gil | director | 2024-12-24 | M-Exempt | 0.01 | 2024-12-26 |
| Rosalind Advisors, Inc. | director | 2024-12-24 | C-Conversion | 10 | 2024-12-26 |
| Rosalind Advisors, Inc. | director | 2024-12-24 | M-Exempt | 0.01 | 2024-12-26 |
| Aharon Gil | director | 2024-10-30 | M-Exempt | 1000 | 2024-11-01 |
| Aharon Gil | director | 2024-10-30 | H-ExpireLong | 0 | 2024-11-01 |
| SALAMON STEVEN A J | director | 2024-10-30 | M-Exempt | 1000 | 2024-11-01 |
| SALAMON STEVEN A J | director | 2024-10-30 | H-ExpireLong | 0 | 2024-11-01 |
| Rosalind Advisors, Inc. | director | 2024-10-30 | H-ExpireLong | 0 | 2024-11-01 |
| Rosalind Advisors, Inc. | director | 2024-10-30 | M-Exempt | 1000 | 2024-11-01 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2024-10-22 | M-Exempt | 6 | 2024-10-23 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2024-10-22 | M-Exempt | 6 | 2024-10-23 |
| CZEREPAK ELIZABETH | director | 2024-05-23 | A-Award | 7.85 | 2024-05-28 |
| Sylvester John Richard | director | 2024-05-23 | A-Award | 7.85 | 2024-05-28 |
| SALAMON STEVEN A J | director | 2024-05-23 | A-Award | 7.85 | 2024-05-28 |
| Aharon Gil | director | 2024-05-23 | A-Award | 7.85 | 2024-05-28 |
| Martell Bridget A | director | 2024-05-23 | A-Award | 7.85 | 2024-05-28 |
| Martell Bridget A | 2024-05-23 | 0 | 2024-05-28 | ||
| STOLL ROGER G PHD | director | 2024-05-23 | A-Award | 11.67 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | A-Award | 7.25 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | A-Award | 10.16 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | A-Award | 6.24 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | A-Award | 196.7 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | D-Return | 11.67 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | D-Return | 6.24 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | D-Return | 10.16 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | D-Return | 7.25 | 2024-05-28 |
| STOLL ROGER G PHD | director | 2024-05-23 | D-Return | 196.7 | 2024-05-28 |
| Aharon Gil | director | 2024-04-18 | X-InTheMoney | 0.01 | 2024-05-16 |
| SALAMON STEVEN A J | director | 2024-04-18 | X-InTheMoney | 0.01 | 2024-05-16 |
| Rosalind Advisors, Inc. | director | 2024-04-18 | X-InTheMoney | 0.01 | 2024-05-16 |
| Aharon Gil | director | 2024-04-18 | C-Conversion | 0 | 2024-05-16 |
| Aharon Gil | director | 2024-04-18 | X-InTheMoney | 6199.46 | 2024-05-16 |
| SALAMON STEVEN A J | director | 2024-04-18 | X-InTheMoney | 6199.46 | 2024-05-16 |
| SALAMON STEVEN A J | director | 2024-04-18 | C-Conversion | 0 | 2024-05-16 |
| Rosalind Advisors, Inc. | director | 2024-04-18 | C-Conversion | 0 | 2024-05-16 |
| Rosalind Advisors, Inc. | director | 2024-04-18 | X-InTheMoney | 6199.46 | 2024-05-16 |
| Aharon Gil | director | 2024-03-19 | P-Purchase | 3.72 | 2024-03-20 |
| SALAMON STEVEN A J | director | 2024-03-19 | P-Purchase | 3.72 | 2024-03-20 |
| Rosalind Advisors, Inc. | director | 2024-03-19 | P-Purchase | 0.01 | 2024-03-20 |
| Rook Martha S. | officer: CHIEF OPERATING OFFICER | 2024-03-18 | A-Award | 4.18 | 2024-03-20 |
| Rook Martha S. | 2024-03-18 | 0 | 2024-03-20 | ||
| Vukovic Vojo | officer: CHIEF MEDICAL OFFICER | 2024-03-19 | A-Award | 3.72 | 2024-03-19 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2024-03-19 | A-Award | 3.72 | 2024-03-19 |
| Pennell Sandra | officer: SVP OF FINANCE, PFO AND PAO | 2024-03-19 | A-Award | 3.72 | 2024-03-19 |
| Muir Kevin | officer: GM INTERVENTIONAL ONCOLOGY | 2024-03-19 | A-Award | 3.72 | 2024-03-19 |
| Hoffman David L. | officer: GEN'L COUNSEL, CCO & SECY | 2024-03-19 | A-Award | 3.72 | 2024-03-19 |
| Dias Anthony | officer: VP FINANCE | 2023-02-08 | A-Award | 4.67 | 2024-02-20 |
| Vukovic Vojo | officer: CHIEF MEDICAL OFFICER | 2024-02-12 | A-Award | 4.78 | 2024-02-14 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2024-02-12 | A-Award | 4.78 | 2024-02-14 |
| Muir Kevin | officer: VP COMMERCIAL OPERATIONS | 2024-02-12 | A-Award | 4.78 | 2024-02-14 |
| Pennell Sandra | officer: SVP OF FINANCE, PFO AND PAO | 2024-02-12 | A-Award | 4.78 | 2024-02-14 |
| Hoffman David L. | officer: GEN'L COUNSEL, CCO & SECY | 2024-02-12 | A-Award | 4.78 | 2024-02-14 |
| Muir Kevin | officer: VP COMMERCIAL OPERATIONS | 2023-02-08 | A-Award | 4.67 | 2024-01-26 |
| Hoffman David L. | officer: GEN'L COUNSEL, CCO & SECY | 2023-02-08 | A-Award | 4.67 | 2024-01-26 |
| Purpura John | officer: CHIEF OPERATING OFFICER | 2023-02-08 | A-Award | 4.67 | 2024-01-26 |
| John Johnny | officer: SVP CLINICAL DEV & MED AFFAIRS | 2023-02-08 | A-Award | 4.67 | 2024-01-26 |
| MICHEL GERARD J | director, officer: CHIEF EXECUTIVE OFFICER | 2023-02-08 | A-Award | 4.67 | 2024-01-26 |
| Vukovic Vojo | officer: Chief Medical Officer | 2023-12-12 | P-Purchase | 3 | 2023-12-14 |
| MICHEL GERARD J | director, officer: Chief Executive Officer | 2023-12-08 | P-Purchase | 2.94 | 2023-12-11 |
| Rosalind Advisors, Inc. | director | 2023-11-17 | P-Purchase | 2.4041 | 2023-11-21 |